Author:
Mollejo M.,Piris Miguel A.
Publisher
Springer International Publishing
Reference23 articles.
1. Audouin, J., Le Tourneau, A., Molina, T., Camilleri-Broet, S., Adida, C., Comperat, E., Benattar, L., Delmer, A., Devidas, A., Rio, B., & Diebold, J. (2003). Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. British Journal of Haematology, 122(3), 404–412.
2. Baseggio, L., Traverse-Glehen, A., Petinataud, F., Callet-Bauchu, E., Berger, F., Ffrench, M., Couris, C. M., Thieblemont, C., Morel, D., Coiffier, B., Salles, G., & Felman, P. (2010). CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases. Haematologica 95(4), 604–612.
3. Curiel-Olmo, S., Mondejar, R., Almaraz, C., Mollejo, M., Cereceda, L., Mares, R., Derdak, S., Campos-Martin, Y., Batlle, A., Gonzalez de Villambrosia, S., Gut, M., Blanc, J., Traverse-Glehen, A., Verney, A., Baseggio, L., Camacho, F. I., Wotherspoon, A., Stamatopoulos, K., Xochelli, A., Papadaki, T., Kanellis, G., Ponzoni, M., Garcia-Cosio, M., Vaque, J. P., Beltran, S., Gut, I., Piris, M. A., & Martinez, N. (2017). Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations. Blood 129(8), 1042–1045.
4. Franco, V., Florena, A. M., & Campesi, G. (1996). Intrasinusoidal bone marrow infiltration: A possible hallmark of splenic lymphoma. Histopathology, 29(6), 571–575.
5. Hamadeh, F., MacNamara, S. P., Aguilera, N. S., Swerdlow, S. H., Cook, J. R. (2014). MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma. Modern Pathology.